A recruiter and a dating coach weigh in on the stress of multiple rounds of interviews before a candidate gets an offer, and share tips for navigating the process.
French
The shift announced by Quebec will follow a similar approach to policies introduced in British Columbia, Alberta and recently in New Brunswick to transition patients who use a reference biologic to a biosimilar. This will contribute to substantial annual savings that can be reinvested in healthcare and innovative new drugs.
The transition will take place under the supervision of the attending physicians and patients will continue receiving safe and effective treatment. Sandoz Canada has a portfolio of six biosimilars (Omnitrope, Rixymio, Erelzi, Hyrimoz, Ziextenzo and Inclunox).
Sandoz Canada is committed to supporting patients, their healthcare professionals and the Quebec government throughout the transition period with quality biosimilar medicines, medical teams, physician and pharmacist advocacy teams, as well as proven patient support programs.
New research by threat detection and response firm Vectra AI shows that the most common threats to corporate networks remain consistent throughout all companies regardless of their size. Researchers calculated the relative frequency of threat detections that were triggered during a three-month span. The results detail the top 10 threat detections that customers receive by relative frequency.